USA-based generics firm Ranbaxy Pharmaceuticals, a wholly-owned subsidiary of India's drug giant Ranbaxy Laboratories, has announced the launch of Riomet (metformin hydrochloride oral solution) 500mg/5mL, the first and only liquid metformin on the market. Metformin is the most prescribed oral treatment for type 2 diabetes, and the company's liquid form may significantly improve the lives of diabetics unable to swallow tablets, an often unrecognized but widespread condition known as dysphagia, affecting one in 17 people to some degree.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze